Evidence map›Paper›PMID 33111769›Full record

ArticleRevista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo2020

MUCOPOLYSACARIDOSIS TYPE IIIB MISDIAGNOSED AS AN AUTISTIC SPECTRUM DISORDER: A CASE REPORT AND LITERATURE REVIEW.

Alan Tibério Dalpiaz Irigonhê, Angélica Malman Thomazine Moreira, Daniel Almeida do Valle, Mara Lúcia Schmitz Ferreira Santos

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Misdiagnosis in mucopolysaccharidoses.Journal of applied genetics · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alan Tibério Dalpiaz IrigonhêUniversidade Positivo, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0003-1855-6034
Angélica Malman Thomazine MoreiraUniversidade Positivo, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0003-2322-7147
Daniel Almeida do ValleUniversidade Positivo, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0001-9005-6726
Mara Lúcia Schmitz Ferreira SantosHospital Pequeno Príncipe, Curitiba, PR, Brazil.ORCID http://orcid.org/0000-0002-5253-988X
Universidade Positivo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo report a rare case of mucopolysaccharidosis IIIB in a pediatric patient, with emphasis on the description of the clinical manifestations and the early diagnosis. CASE DESCRIPTION: A 14-year-old male patient, who presented regression of neuropsychomotor development since his three years and six months old, with speech loss and frequent falls, evolving with behavioral changes, with agitation and aggressiveness. Although being diagnosed with autism, there was no response to the established treatment; he was subsequently submitted to metabolic investigation, which lead to the diagnosis of Mucopolysaccharidosis IIIB. COMMENTS: Identifying a metabolic disorder requires connecting multiple signs and symptoms, as well as eliminating other apparent causes. MPS IIIB is a diagnostic challenge, particularly in the early stages and in the absence of a family history of the disease.

Indexed as

AcetylglucosaminidaseAdolescentAutism Spectrum DisorderDiagnostic ErrorsHumansMaleMucopolysaccharidosis IIIAcetylglucosaminidasealpha-N-acetyl-D-glucosaminidase

Identifiers

PMID33111769
PMCPMC7584028
OpenAlexW3094170815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.